Drug Resistance Profile: Strongest Independent Prognostic Factor in Childhood Acute Lymphoblastic Leukemia in a BFM-Oriented Treatment Protocol

[1]  R. Pieters,et al.  Drug Resistance in Leukemia and Lymphoma III , 2012, Advances in Experimental Medicine and Biology.

[2]  R. Pieters,et al.  Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay. , 1994, British Journal of Cancer.

[3]  R. Pieters,et al.  Different cellular drug resistance profiles in childhood lymphoblastic and non-lymphoblastic leukemia: a preliminary report. , 1994, Leukemia.

[4]  R. Pieters,et al.  In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood. , 1991, British Journal of Cancer.

[5]  R. Pieters,et al.  Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia , 1991, The Lancet.

[6]  A. G. Bosanquet.  Correlations between therapeutic response of leukaemias and in-vitro drug-sensitivity assay , 1991, The Lancet.

[7]  R. Pieters,et al.  In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions , 1990 .

[8]  R. Pieters,et al.  DRUG SENSITIVITY ASSAYS IN LEUKAEMIA AND LYMPHOMA , 1990, British journal of haematology.

[9]  T. Hongo,et al.  An in vitro chemosensitivity test for the screening of anti‐cancer drugs in childhood leukemia , 1990, Cancer.

[10]  C. Paul,et al.  In vitro drug testing in patients with acute leukemia with incubations mimicking in vivo intracellular drug concentrations , 1989, European journal of haematology.

[11]  S. Sallan,et al.  In vitro and in vivo killing of acute lymphoblastic leukemia cells by L-asparaginase. , 1989, Cancer research.

[12]  C. Taylor,et al.  Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia. , 1989, British Journal of Cancer.

[13]  A. Delmer,et al.  Multivariate analysis of prognostic factors in acute myeloid leukemia: value of clonogenic leukemic cell properties. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  R. Pieters,et al.  Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia. , 1989, British Journal of Cancer.

[15]  J. Finklestein,et al.  Laboratory detection of primary and acquired drug resistance in human lymphatic neoplasms. , 1986, Cancer treatment reports.

[16]  P. Roberson,et al.  Correlation of drug sensitivity in vitro with clinical responses in childhood acute myeloid leukemia. , 1986, Blood.

[17]  P. Smith,et al.  Prediction of remission induction in childhood acute myeloid leukemia. , 1986, Australian and New Zealand journal of medicine.

[18]  T. Olofsson,et al.  Prediction of response to chemotherapy in acute leukemia by in vitro drug sensitivity testing on leukemic stem cells. , 1984, Cancer research.

[19]  B. Hoogstraten,et al.  Prediction of chemotherapy response in human leukemia using an in vitro chemotherapy sensitivity test on the leukemic colony-forming cells. , 1980, Blood.

[20]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[21]  J. V. van Dongen,et al.  Contribution of electron microscopy to the classification of minimally differentiated acute leukemias in children. , 1993, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[22]  V. Diehl,et al.  Pretherapeutic drug testing in acute leukemias for prediction of individual prognosis. , 1990, Haematology and blood transfusion.

[23]  D. Cox.  Regression Models and Life-Tables , 1972 .